⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Japan Cell and Gene Therapy Manufacturing Market Forecast to 2035 | Market to Reach USD 5.15 Billion at 29.0% CAGR as Commercial-Scale Capacity and Gene Therapies Expand
globenewswire.com
TMO
CAT
CRL
AMGN
BMY
GILD
AZN
NVS
MRK
JNJ
LLY
ABBV
Global Orphan Drugs Market Size, Share, Trends, and Forecast 2026-2034 | Market to Reach USD 589.2 Billion as Genomics, Precision Medicine, and Regulatory Incentives Drive Growth
globenewswire.com
AMGN
AZN
GNE
GSK
JNJ
MRK
NVS
PFE
SNY
BMY
REGN
BIIB
GILD
ABBV
EXEL
CRSP
NTLA
EDIT
INCY
VRTX
Orphan Drugs - Global Market Size, Share, Industry Trends, and Growth Forecasts, 2025-2031 | Biologics and Asia-Pacific Drive 6.36% CAGR to USD 334.28 Billion
globenewswire.com
ABBV
AMGN
AZN
BMRN
BMY
CSL
GSK
JNJ
NVS
PFE
REGN
SNY
SRPT
VRTX
Global Immunotherapy Drugs Market - Size, Share, Trends, Competitive Landscape, and Forecast - 2034 | Market to Reach USD 837.14 Billion as Cell Therapies Drive 13.05% CAGR
globenewswire.com
MRK
BMY
NVS
ROG
AMGN
IBIO
AZN
JNJ
GSK
IOVA
ABBV
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Novartis AG - NVS
accessnewswire.com
NVS
Breast Cancer Continues to Impact Communities; New York Rallies Together to Take Action at Susan G. Komen® MORE THAN PINK Walk
businesswire.com
PFE
LLY
NTRA
DGX
GH
NVS
Over Two Million Reached Through the American Cancer Society and NFL's Focus on Increasing Cancer Screening
prnewswire.com
NVS
Global Digital Biomarkers Market Size, Share, Trends, and Forecast, 2026-2036 | AI, Wearables, and Decentralized Trials Drive 13.4% CAGR to USD 34.6 Billion
globenewswire.com
AAPL
GOOGL
ABT
MDLZ
PHG
BIIB
NVS
SNY
ORO Labs Partners with SAP to Deliver Procurement Orchestration as a Solution Extension
prnewswire.com
SAP
KO
PFE
NVS
BMY
GSK
IBM
OMLYCLO® (omalizumab-igec), the first and only FDA-approved interchangeable biosimilar to XOLAIR®, now commercially available in the U.S.
prnewswire.com
NVS